European Respiratory Journal
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Endothelial cells in pulmonary fibrosis: more than a bystander.
61:2300407-2300407.
2023
-
A novel take on idiopathic pulmonary fibrosis disease progression: localised autoimmunity.
61:2300653-2300653.
2023
-
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study.
61:2202163-2202163.
2023
-
Another piece in the pirfenidone puzzle.
61:2300240-2300240.
2023
-
Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary Fibrosis.
61:2300208-2300208.
2023
-
Idiopathic pulmonary fibrosis: state of the art for 2023.
61:2200957-2200957.
2023
-
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
61:2201193-2201193.
2023
-
Progressive pulmonary fibrosis: an expert group consensus statement.
61:2103187-2103187.
2023
-
European Respiratory Society guideline on various aspects of quality in lung cancer care.
61:2103201-2103201.
2023
-
Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!.
61:2201797-2201797.
2023
-
3D (bio)printing of lungs: past, present, and future.
61:2200417-2200417.
2023
-
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms.
61:2200970-2200970.
2023
-
Reply to: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis.
61:2202261-2202261.
2023
-
Airway autoantibodies are determinants of asthma severity.
60:2200442-2200442.
2022
-
Lung cancer in pulmonary fibrosis: no room for nihilism!.
60:2201946-2201946.
2022
-
Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
60:2102446-2102446.
2022
-
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
60:2102571-2102571.
2022
-
European Respiratory Society guidelines for the diagnosis of asthma in adults.
60:2101585-2101585.
2022
-
Moving the dial on identifying endotypes of asthma from early life.
60:2201031-2201031.
2022
-
Allergen provocation tests in respiratory research: building on 50 years of experience.
60:2102782-2102782.
2022
-
Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar–capillary barrier function during influenza infection.
60:2102049-2102049.
2022
-
Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?.
60:2102103-2102103.
2022
-
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343–373..
59:1362020-1362020.
2022
-
Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.
59:2102899-2102899.
2022
-
Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity.
59:2102210-2102210.
2022
-
ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure.
59:2101574-2101574.
2022
-
Prognostic factors for development of acute respiratory distress syndrome following traumatic injury: a systematic review and meta-analysis.
59:2100857-2100857.
2022
-
Helmet noninvasive ventilation compared to facemask noninvasive ventilation and high-flow nasal cannula in acute respiratory failure: a systematic review and meta-analysis.
59:2101269-2101269.
2022
-
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
59:2004538-2004538.
2022
-
Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.
59:2101399-2101399.
2022
-
Tuberculosis and COVID-19 co-infection: description of the global cohort.
59:2102538-2102538.
2022
-
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
59:2101471-2101471.
2022
-
Is tezepelumab more than just an anti-eosinophil drug?.
59:2101700-2101700.
2022
-
R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.
59:2100917-2100917.
2022
-
The evolution of the European Respiratory Journal: adapting in an era of change.
59:2200037-2200037.
2022
-
Occupational inhalant exposures and longitudinal lung function decline.
58:2004341-2004341.
2021
-
Steroid use in elderly critically ill COVID-19 patients.
58:2100979-2100979.
2021
-
The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial.
58:2002819-2002819.
2021
-
Exercise-induced bronchoconstriction and bronchodilation: investigating the effects of age, sex, airflow limitation and FEV1.
58:2004026-2004026.
2021
-
Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis.
58:2100172-2100172.
2021
-
Repeat bronchoalveolar lavage in idiopathic pulmonary fibrosis: proceed with caution?.
57:2100691-2100691.
2021
-
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study.
57:2002688-2002688.
2021
-
Guideline-directed management of COVID-19: Do's and Don'ts.
57:2100753-2100753.
2021
-
The management of mild asthma.
57:2003051-2003051.
2021
-
Mononuclear phagocytic system and fibrosis: back to the future?.
57:2004466-2004466.
2021
-
Reply to: Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough.
57:2100245-2100245.
2021
-
Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction.
57:2000839-2000839.
2021
-
Current smoking status is associated with reduced sputum immunoglobulin M and G expression in COPD.
57:1902338-1902338.
2021
-
The case of methotrexate and the lung: Dr Jekyll and Mr Hyde.
57:2100079-2100079.
2021
-
The evolution of the European Respiratory Journal: weathering the publishing pandemic.
57:2100084-2100084.
2021
-
A golden age of asthma research.
56:2003820-2003820.
2020
-
The effect of pain conditioning on experimentally evoked cough: evidence of impaired endogenous inhibitory control mechanisms in refractory chronic cough.
56:2001387-2001387.
2020
-
Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow.
56:2003147-2003147.
2020
-
Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care.
56:1902246-1902246.
2020
-
“ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.” Alyn H. Morice, Eva Millqvist, Kristina Bieksiene, Surinder S. Birring, Peter Dicpinigaitis, Christian Domingo Ribas, Michele Hilton Boon, Ahmad Kantar, Kefang Lai, Lorcan McGarvey, David Rigau, Imran Satia, Jacky Smith, Woo-Jung Song, Thomy Tonia, Jan W.K. van den Berg, Mirjam J.G. van Manen and Angela Zacharasiewicz. Eur Respir J 2020; 55: 1901136..
56:1951136-1951136.
2020
-
Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena.
56:2000117-2000117.
2020
-
Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-like pathologies in mice.
56:2000404-2000404.
2020
-
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.
56:2001123-2001123.
2020
-
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.
56:2000535-2000535.
2020
-
TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
55:1901346-1901346.
2020
-
The importance of interventional timing in the bleomycin model of pulmonary fibrosis.
55:1901105-1901105.
2020
-
Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation.
55:1901760-1901760.
2020
-
EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.
55:1901104-1901104.
2020
-
Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis?.
55:2000318-2000318.
2020
-
Prognostic impact of typical and probable usual interstitial pneumonia pattern in idiopathic pulmonary fibrosis: is the debate about biopsy a Star Wars saga?.
55:2000590-2000590.
2020
-
WHO guidance on multidrug-resistant tuberculosis treatment: using and communicating the evidence.
55:1902325-1902325.
2020
-
Clinical implications of incidental venous thromboembolism in cancer patients.
55:1901697-1901697.
2020
-
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.
55:1901136-1901136.
2020
-
European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia.
55:1900788-1900788.
2020
-
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.
55:1900588-1900588.
2020
-
The evolution of the European Respiratory Journal: ready for the new decade!.
55:1902503-1902503.
2020
-
From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity.
54:1901023-1901023.
2019
-
The impact of marijuana smoking on lung function.
54:1902065-1902065.
2019
-
European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD.
54:1901003-1901003.
2019
-
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases.
54:1900161-1900161.
2019
-
The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group.
54:1901511-1901511.
2019
-
The Global Initiative for Asthma (GINA): 25 years later.
54:1900598-1900598.
2019
-
An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13.
54:1802041-1802041.
2019
-
Asthma progression and mortality: the role of inhaled corticosteroids.
54:1900491-1900491.
2019
-
Eosinophil-derived IL-13 promotes emphysema.
53:1801291-1801291.
2019
-
The Electronic Asthma Management System (eAMS) improves primary care asthma management.
53:1802241-1802241.
2019
-
Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.
53:1801655-1801655.
2019
-
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis.
53:1800663-1800663.
2019
-
Pulmonary fibrosis: “idiopathic” is not “cryptogenic”.
53:1900400-1900400.
2019
-
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?.
53:1801939-1801939.
2019
-
Predictors of 1-year compliance with adaptive servoventilation in patients with heart failure and sleep disordered breathing: preliminary data from the ADVENT-HF trial.
53:1801626-1801626.
2019
-
The interleukin-13 paradox in asthma: effective biology, ineffective biologicals.
53:1802250-1802250.
2019
-
The evolution of theEuropean Respiratory Journal: volume 2.
53:1802459-1802459.
2019
-
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing.
52:1801033-1801033.
2018
-
Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.
52:1701857-1701857.
2018
-
Radiological diagnosis of interstitial lung disease: is it all about pattern recognition?.
52:1801321-1801321.
2018
-
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis.
52:1702593-1702593.
2018
-
A systematic review on how patients value chronic obstructive pulmonary disease outcomes.
52:1800222-1800222.
2018
-
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373..
52:1352020-1352020.
2018
-
What is the minimal clinically important difference for helium-3 magnetic resonance imaging ventilation defects?.
51:1800324-1800324.
2018
-
Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study.
51:1702375-1702375.
2018
-
Optimising experimental research in respiratory diseases: an ERS statement.
51:1702133-1702133.
2018
-
What's in a name? That which we call IPF, by any other name would act the same.
51:1800692-1800692.
2018
-
Associations between blood eosinophils and decline in lung function among adults with and without asthma.
51:1702536-1702536.
2018
-
Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis.
51:1700386-1700386.
2018
-
“Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143–178..
51:0751387-0751387.
2018
-
The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?.
51:1702420-1702420.
2018
-
Turning thirty: evolution but not revolution at the ERJ.
51:1702594-1702594.
2018
-
A standardised method for interpreting the association between mutations and phenotypic drug resistance inMycobacterium tuberculosis.
50:1701354-1701354.
2017
-
Association of wheeze with lung function decline in children with sickle cell disease.
50:1602433-1602433.
2017
-
Sex-specific impact of asthma during pregnancy on infant gut microbiota.
50:1700280-1700280.
2017
-
The paradoxes of asthma management: time for a new approach?.
50:1701103-1701103.
2017
-
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study.
50:1700936-1700936.
2017
-
Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.
50:1602426-1602426.
2017
-
Acute exacerbations of idiopathic pulmonary fibrosis: tough to define; tougher to manage.
49:1700811-1700811.
2017
-
Breastfeeding, maternal asthma and wheezing in the first year of life: a longitudinal birth cohort study.
49:1602019-1602019.
2017
-
ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
49:1601526-1601526.
2017
-
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis.
49:1602486-1602486.
2017
-
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.
49:1602308-1602308.
2017
-
Heat shock protein: a hot topic in idiopathic pulmonary fibrosis.
49:1602152-1602152.
2017
-
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment.
48:1369-1376.
2016
-
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns.
48:1524-1526.
2016
-
Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia.
48:1150-1159.
2016
-
Pulmonary function tests (PFT) and sleep disordered breathing (SDB) in morbidly obese children and adults:.
48:PA4348-PA4348.
2016
-
The relationship between body fat and respiratory function in young adults.
48:734-747.
2016
-
“Plasma pro-surfactant protein B and lung function decline in smokers.” Janice M. Leung, John Mayo, Wan Tan, C. Martin Tammemagi, Geoffrey Liu, Stuart Peacock, Frances A. Shepherd, John Goffin, Glenwood Goss, Garth Nicholas, Alain Tremblay, Michael Johnston, Simon Martel, Francis Laberge, Rick Bhatia, Heidi Roberts, Paul Burrowes, Daria Manos, Lori Stewart, Jean M. Seely, Michel Gingras, Sergio Pasian, Ming-Sound Tsao, Stephen Lam and Don D. Sin, for the Pan-Canadian Early Lung Cancer Study Group. Eur Respir J 2015; 45: 1037–1045..
48:962.2-962.
2016
-
Is ventilation heterogeneity related to asthma control?.
48:370-379.
2016
-
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
48:187-195.
2016
-
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.
47:1776-1784.
2016
-
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
47:1028-1033.
2016
-
Amoxicillin for clinically unsuspected pneumonia in primary care: subgroup analysis.
47:327-330.
2016
-
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
46:1563-1576.
2015
-
Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice.
46:1451-1460.
2015
-
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations.
46:1055-1064.
2015
-
A summary of the new GINA strategy: a roadmap to asthma control.
46:622-639.
2015
-
Allergen-induced airway responses.
46:819-831.
2015
-
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials.
46:243-249.
2015
-
Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?.
46:287-288.
2015
-
Effects of quitting cannabis on respiratory symptoms.
46:80-87.
2015
-
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
45:1434-1445.
2015
-
Plasma pro-surfactant protein B and lung function decline in smokers.
45:1037-1045.
2015
-
Smoking, asthma, chronic airflow obstruction and COPD.
45:586-588.
2015
-
Defining airflow obstruction.
45:563-564.
2015
-
Impacts of peroxisome proliferator-activated receptor-γ activation on cigarette smoke-induced exacerbated response to bacteria.
45:191-200.
2015
-
An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.
44:1479-1503.
2014
-
Mechanisms of exercise intolerance in Global Initiative for Chronic Obstructive Lung Disease grade 1 COPD.
44:1177-1187.
2014
-
"Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness." Kalina T. Zlateva, Jutte J.C. de Vries, Frank E.J. Coenjaerts, Anton M. van Loon, Theo Verheij, Paul Little, Christopher C. Butler, Herman Goossens, Margareta Ieven and Eric C.J. Claas on behalf of the GRACE Study Group. Eur Respir J 2014; 44: 169-177..
44:556-556.
2014
-
Integrated care pathways for airway diseases (AIRWAYS-ICPs).
44:304-323.
2014
-
Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
44:267-267.
2014
-
Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
44:267-268.
2014
-
Prevalence and correlates of airflow obstruction in 317 000 never-smokers in China.
44:66-77.
2014
-
Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness.
44:169-177.
2014
-
Differences in content and organisational aspects of pulmonary rehabilitation programmes.
43:1326-1337.
2014
-
"International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343-373..
43:1216-1216.
2014
-
Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis.
43:817-823.
2014
-
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.
43:773-782.
2014
-
Asymmetric dimethylarginine and asthma.
43:647-648.
2014
-
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma.
43:627-629.
2014
-
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
43:343-373.
2014
-
Safety of formoterol in asthma clinical trials: an update.
43:103-114.
2014
-
“Biomarker-guided clinical decisions: for patients, health economists or neither?” Jens-Ulrik Jensen.Eur Respir J2013; 42: 895–897..
42:1432.2-1432.
2013
-
Diagnosing pneumonia in patients with acute cough: clinical judgment compared to chest radiography.
42:1076-1082.
2013
-
Sample sizes for clinical trials using sputum eosinophils as a primary outcome.
42:1003-1011.
2013
-
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis.
42:230-238.
2013
-
Age and height dependence of lung clearance index and functional residual capacity.
41:1371-1377.
2013
-
Previous general practitioner consulting behaviour as a predictor of pneumonia in children.
41:1233-1234.
2013
-
Consensus statement for inert gas washout measurement using multiple- and single- breath tests.
41:507-522.
2013
-
PPAR ligands decrease human airway smooth muscle cell migration and extracellular matrix synthesis.
41:425-432.
2013
-
Prof. Andrzej Szczeklik, 1938–2012: aspirin-induced asthma and much more.
39:1286-1286.
2012
-
“Effect of different asthma treatments on risk of cold-related exacerbations.” H.K. Reddel, C. Jenkins, S. Quirce, M.R. Sears, E.D. Bateman, P.M. O'Byrne, M. Humbert, R. Buhl, T. Harrison, G.G. Brusselle, A. Thorén, U. Sjöbring, S. Peterson, O. Östlund and G.S. Eriksson.Eur Respir J2011; 38: 584–593.: Figure 4.
39:1280-1280.
2012
-
Chest radiotherapy to achieve lung volume reduction.
39:792-792.
2012
-
Interleukin-18 and interleukin-18 receptor- expression in allergic asthma.
38:981-983.
2011
-
Effect of different asthma treatments on risk of cold-related exacerbations.
38:584-593.
2011
-
Mechanisms of dyspnoea relief following radiation treatment in a patient with severe COPD.
38:728-730.
2011
-
Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma.
38:679-687.
2011
-
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.
38:516-528.
2011
-
A mouse GM-CSF receptor antibody attenuates neutrophilia in mice exposed to cigarette smoke.
38:285-294.
2011
-
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines.
38:112-118.
2011
-
Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection.
38:119-125.
2011
-
From the authors: The Asthma Control Questionnaire for children: still more questions than answers.
37:1534-1535.
2011
-
In memoriam Prof. Hisamichi Aizawa, 1950-2011.
37:977-977.
2011
-
The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis.
37:806-812.
2011
-
The promise of electronic data capture in respiratory medicine.
37:228-230.
2011
-
Asthma Control Questionnaire in children: validation, measurement properties, interpretation.
36:1410-1416.
2010
-
Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs.
36:1131-1142.
2010
-
Overexpression of transforming growth factor- 1 in fetal monkey lung results in prenatal pulmonary fibrosis.
36:907-914.
2010
-
Measuring asthma control: a comparison of three classification systems.
36:269-276.
2010
-
Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries.
35:761-767.
2010
-
Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles.
35:176-185.
2010
-
Effects of cannabis on lung function: a population-based cohort study.
35:42-47.
2010
-
Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study.
35:48-53.
2010
-
Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma.
34:1489-1492.
2009
-
Validated questionnaires should not be modified.
34:1015-1017.
2009
-
How to increase the value of randomised trials in COPD research.
34:552-558.
2009
-
Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo.
33:1437-1447.
2009
-
Single-dose desloratadine and montelukast and allergen-induced late airway responses.
33:1302-1308.
2009
-
Asthma therapy: how far have we come, why did we fail and where should we go next?.
33:11-20.
2009
-
Long-acting -agonists: a review of formoterol safety data from asthma clinical trials.
33:21-32.
2009
-
Properties of a store-operated nonselective cation channel in airway smooth muscle.
32:1529-1538.
2008
-
The Brussels Declaration: the need for change in asthma management.
32:1433-1442.
2008
-
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice.
32:970-978.
2008
-
The effect of inhaled lidocaine-hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis.
32:1119-1122.
2008
-
A new perspective on concepts of asthma severity and control.
32:545-554.
2008
-
Interpretation of treatment changes in 6-minute walk distance in patients with COPD.
32:637-643.
2008
-
Ryanodine receptors decant internal Ca2+ store in human and bovine airway smooth muscle.
32:275-284.
2008
-
TGF- receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung.
32:285-295.
2008
-
Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma.
31:982-989.
2008
-
Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique.
31:532-538.
2008
-
COPD dashboard: about official Documents, Authors, Science, Health status and BOARDs.
31:238-240.
2008
-
COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation.
31:304-310.
2008
-
Global strategy for asthma management and prevention: GINA executive summary.
31:143-178.
2008
-
Population prevalence of COPD.
31:218-218.
2008
-
Three-dimensional computed tomography imaging in an animal model of emphysema.
30:1082-1089.
2007
-
"HOW MUCH IS TOO MUCH? THE TREATMENT OF MILD ASTHMA". P.M. O'BYRNE. EUR RESPIR J 2007; 30: 403 406..
30:1026-1026.
2007
-
Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase.
30:1014-1017.
2007
-
Kinetics of in vitro bronchoconstriction in an elastolytic mouse model of emphysema.
30:691-700.
2007
-
A common presentation with a rare cause.
30:594-597.
2007
-
How much is too much? The treatment of mild asthma.
30:403-406.
2007
-
Lung function decline in asthma.
30:411-413.
2007
-
Store-refilling involves both L-type calcium channels and reverse-mode sodium calcium exchange in airway smooth muscle.
30:269-278.
2007
-
Ionic mechanisms and Ca2+ handling in airway smooth muscle.
30:114-133.
2007
-
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma.
29:834-860.
2007
-
Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli.
28:703-711.
2006
-
Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli..
28:703-711.
2006
-
Asthma, COPD and bronchitis are just components of airway disease.
28:264-267.
2006
-
Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology.
27:441-445.
2006
-
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.
27:483-494.
2006
-
Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome.
26:679-685.
2005
-
Efficacy of fluticasone on cough.
26:181-181.
2005
-
In memoriam Romain Pauwels.
25:585-586.
2005
-
A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire.
25:31-40.
2005
-
Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
25:41-46.
2005
-
Extracellular matrix regulates human airway smooth muscle cell migration.
24:545-551.
2004
-
Effect of freezing of sputum samples on flow cytometric analysis of lymphocyte subsets.
24:309-312.
2004
-
Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?.
24:1-2.
2004
-
Limitation to muscular activity in chronic obstructive pulmonary disease.
24:6-7.
2004
-
Relationship between quality of life and clinical status in asthma: a factor analysis.
23:287-291.
2004
-
The influence of lung volume reduction surgery on exercise in patients with COPD.
23:269-274.
2004
-
A method to preserve sputum for delayed examination.
22:996-1000.
2003
-
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
22:787-794.
2003
-
Erratum: "Indirect airway challenges" (European Respiratory Journal (2003) vol. 21 (1050-1068)).
22:718.
2003
-
Murine models of asthma.
22:374-382.
2003
-
Indirect airway challenges.
21:1050-1068.
2003
-
Uptake of18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?.
21:848-854.
2003
-
Clinical applications of assessment of airway inflammation using induced sputum.
20:40S-43s.
2002
-
The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease.
20:20-29.
2002
-
The use of induced sputum in clinical trials.
20:47S-50s.
2002
-
International approaches to the prescription of long-term oxygen therapy.
18:909-913.
2001
-
Increased detection of interleukin-;5 in sputum by addition of protease inhibitors.
18:685-691.
2001
-
Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma.
18:38-44.
2001
-
The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma.
18:45-52.
2001
-
The reproducibility and sample size requirements of exercise-induced bronchoconstriction measurements.
17:581-588.
2001
-
Lipid-laden macrophages in induced sputum are a marker of oropharyngeal reflux and possible gastric aspiration.
16:1119-1122.
2000
-
"Induced sputum cell counts: their usefulness in clinical practice" (vol 16, pg 150, 2000).
16:1029-1029.
2000
-
Induced sputum cell counts: their usefulness in clinical practice.
16:150-158.
2000
-
Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma.
15:486-490.
2000
-
Comparison of two standardized methods of methacholine inhalation challenge in young adults.
15:181-184.
2000
-
The relationship between moisture or mould observations in houses and the state of health of their occupants.
14:1363-1367.
1999
-
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.
14:1038-1043.
1999
-
Development and validation of a questionnaire to measure asthma control.
14:902-902.
1999
-
Development and validation of the Mini Asthma Quality of Life Questionnaire.
14:32-32.
1999
-
Measurements of dyspnoea during bronchoconstriction.
13:943-943.
1999
-
Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.
13:1029-1029.
1999
-
Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.
13:1029-1036.
1999
-
Bronchoalveolar lavage findings in patients with chronic nonproductive cough.
13:66-70.
1999
-
Cyclophosphamide pulse therapy in idiopathic pulmonary fibrosis.
12:1409-1414.
1998
-
Evidence for mast cell activation during exercise-induced bronchoconstriction.
12:345-350.
1998
-
Effects of cromolyn and nedocromil on ion currents in canine tracheal smooth muscle.
12:50-56.
1998
-
Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators.
12:30-34.
1998
-
Serial sputum cell counts in the management of chronic airflow limitation.
11:1405-1408.
1998
-
Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics.
11:821-827.
1998
-
Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared.
11:828-834.
1998
-
Assessment of airway inflammation: an overview..
26:6S-8S.
1998
-
Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
11:589-593.
1998
-
Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire (CRQ).
11:55-60.
1998
-
Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society.
10:2662-2689.
1997
-
Effects of beta-agonists on dose-response curves.
10:2434-2435.
1997
-
Effects of beta-agonists on dose-response curves - Reply.
10:2434-2435.
1997
-
Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties.
10:2285-2294.
1997
-
Measurement characteristics of two asthma symptom diary scales for use in clinical trials.
10:646-651.
1997
-
Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
10:330-336.
1997
-
Use of peak expiratory flow meters in adults: practical aspects..
24:72S-74S.
1997
-
Comparison of reported prevalences of recent asthma in longitudinal and cross-sectional studies.
10:51-54.
1997
-
Induced sputum to assess airway inflammation in asthma.
9:2435-2436.
1996
-
A case for serial examination of sputum inflammatory cells.
9:2174-2175.
1996
-
Increased peak flow variability in children with asymptomatic hyperresponsiveness.
8:1731-1735.
1995
-
Some technical factors influencing the induction of sputum for cell analysis.
8:559-565.
1995
-
Immune-inflammatory functions of fibroblasts.
7:2212-2222.
1994
-
The effects of indomethacin on refractoriness following exercise both with and without a bronchoconstrictor response.
7:2174-2178.
1994
-
Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma.
7:1576-1584.
1994
-
Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness.
6:1249-1256.
1993
-
Factors contributing to dyspnoea during bronchoconstriction and exercise in asthmatic subjects.
6:1004-1010.
1993
-
Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults.
6:53-83.
1993
-
Is nedocromil sodium effective treatment for asthma?.
6:5-6.
1993
-
Regular beta-agonist therapy--the quality of the evidence.
5:896-897.
1992
-
International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication no. 92-3091, March 1992.
5:601-641.
1992
-
Effort and dyspnoea during work of varying intensity and duration.
4:917-925.
1991
-
The role of thromboxane in allergen-induced asthmatic responses.
4:667-672.
1991
-
Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight.
4:188-190.
1991
-
Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics.
3:1122-1127.
1990
-
Assessment of disability.
3:989-990.
1990
-
The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness.
2:782-786.
1989
-
Measuring health status in chronic airflow limitation.
1:560-564.
1988
-
Assessment of dyspnoea.
1:195-197.
1988
-
Asthma and the role of inflammation..
147:16-21.
1986
-
Why are deaths from asthma increasing?.
147:175-181.
1986
-
Nasal cilia in normal man, primary ciliary dyskinesia and other respiratory diseases: analysis of motility and ultrastructure..
127:64-70.
1983
-
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance..
121:79-88.
1982
-
Breathing during exercise in airway obstruction..
17:737-739.
1981
-
Tidal volume during exercise in patients with diffuse fibrosing alveolitis..
15:321-328.
1979
-
The place of exercise testing in the investigation of patients with respiratory disorders..
13:425-439.
1977
-
Alarmin Expression in the Upper and Lower Airways of Asthmatics with Allergic Rhinitis
2022
-
Asthma exacerbation rate reduction with benralizumab in an integrated analysis of the real-world XALOC-1 study
2022
-
Awake Prone Positioning in Acute Hypoxemic Respiratory Failure from COVID-19: A Randomized Clinical Trial
2022
-
Benralizumab attenuates blood and airway eosinophilia in severe asthmatics with inadequate response to anti-IL-5 neutralizing antibodies
2022
-
Canadian health care professionals’ experiences diagnosing chronic cough – results from a healthcare survey
2022
-
Canadian health care professionals’ familiarity with chronic cough, its impact on patients, and guideline recommendations of the diagnosis and treatment of chronic cough
2022
-
Canadian health care professionals’ perceptions on the management and effectiveness of treatment of chronic cough – results from a healthcare sample survey
2022
-
Capsaicin evoked cough responses and the effect of sex hormones
2022
-
Comparison of upper and lower airway expression of SARS-COV-2 receptors in mild allergic asthmatics
2022
-
Determinants of DLCO and contribution to exercise capacity and symptoms
2022
-
Features and quality of COPD self-management apps in the Android marketplace
2022
-
Functional recovery of hospitalised patients with covid-19: a prospective cohort study
2022
-
Higher versus lower dose corticosteroids for moderate to severe COVID-19: a systematic review, dose response and network meta-analysis.
2022
-
Impact of mental health and personality traits on the incidence of chronic cough in the Canadian Longitudinal Study on Aging (CLSA)
2022
-
Nasal polyposis in severe asthma is associated with airway autoimmunity towards eosinophils and macrophages
2022
-
Phosphoinositide 3-kinase and airway infections in severe asthmatics
2022
-
Phosphoinositide-3 kinase antagonism does not reverse steroid insensitivity in severe asthma
2022
-
Rapid Access Rehabilitation after exacerbations of COPD – an international Delphi study
2022
-
Reduced ACE2 and TMPRSS2 immunopositive bronchial cells in asthmatics after inhaled allergen challenge
2022
-
Respiratory system resistance and reactance following recovery from non-critical COVID-19
2022
-
The Effect of Inhaled Salbutamol on Mannitol Evoked Cough Responses: A Double-Blind Randomized Placebo Controlled 2-way Cross-Over Study
2022
-
Validation of cough monitoring by Albus Home RD, a contactless bedside device for nocturnal monitoring
2022
-
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
2021
-
Prevalence, incidence, and characteristics of chronic cough among adults from the canadian longitudinal study on ageing (CLSA)
2021
-
Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic
2021
-
Rapid Access Rehabilitation after exacerbations of COPD – A qualitative study
2021
-
The impact of Beta Blockade on cardio-respiratory system and symptoms during exercise
2021
-
Airway autoimmunity and response to a 14-day course of oral corticosteroids in patients with severe eosinophilic asthma
2020
-
Assessing the caregiving experience in COPD: content validity of the Zarit Burden Interview and Caregiver Reaction Assessment
2020
-
CD6-ALCAM Pathway is Elevated in Patients with Severe Asthma
2020
-
Characterisation of the neutrophilic asthma phenotype over time
2020
-
Characteristics of patients with COPD using mobile apps in daily life
2020
-
Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps
2020
-
Home-based fall prevention for older adults with COPD: a feasibility study
2020
-
How is ultrasound imaging being used to assess respiratory musculature? A systematic review
2020
-
Outcomes in exercise-based interventions in interstitial lung diseases
2020
-
A single-center observational study assessing response to mepolizumab in severe eosinophilic asthma
2019
-
An assessment of the use of palivizumab over 12 years from a Canadian Registry (CARESS)
2019
-
Psychometric properties of measures of field-based exercise test capacity in individuals with asthma: a systematic review
2019
-
Relationship between distress and physical activity in informal carers of patients with COPD
2019
-
Relationship between exposure to household air pollution and asthma in children: a systematic review and meta-analysis
2019
-
The prevalence of bronchitis and associations with spirometry in patients with interstitial lungdisease in a Canadian tertiary care centre
2019
-
Understanding the relationship between breastfeeding and childhood asthma: A systematic review and meta-analysis
2019
-
Assessing caregiving experience in COPD: content validity of the Zarit Burden Interview
2018
-
Cost-effectiveness of a single inhaler triple therapy versus ICS/LABA in COPD
2018
-
Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
2018
-
Diffuse panbronchiolitis is not restricted to east asia - A mini literature review
2018
-
Economic and quality of life consequences of clinically important deterioration in patients with COPD: results from the TORCH study
2018
-
Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study
2018
-
Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain
2018
-
Increased sputum B cells in severe eosinophilic asthma: a local auto-inflammatory process
2018
-
Interval versus continuous cycling in advanced interstitial lung disease
2018
-
Investigating the safety of capsaicin cough challenge in severe asthma
2018
-
Late Breaking Abstract - IMPACT study - single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: healthcare resource utilization and costs - UK
2018
-
Late Breaking Abstract - Trial of c-reactive protein point of care testing (CRP-POCT) for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD) in primary care
2018
-
Qualitative research evaluating patient preferences for a new COPD treatment
2018
-
Skeletal limb muscle oxygenation and regional blood volume during incremental loading in interstitial lung disease
2018
-
A novel device for the measurement of carbon dioxide during tidal breathing in COPD
2017
-
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
2017
-
Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD
2017
-
Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
2017
-
Cost effectiveness of umeclidinium bromide 62.5μg plus ICS/LABA versus ICS/LABA in COPD
2017
-
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data
2017
-
Cost-effectiveness of umeclidinium bromide 62.5µg or alternative LAMA plus ICS/LABA in COPD
2017
-
Evaluation of novel LOXL2-selective inhibitors in models of pulmonary fibrosis
2017
-
Lung clearance index is increased in high-risk preschool wheezers and is associated with asthma control
2017
-
Normative values for the Unsupported Upper Limb Exercise (UULEX) test and 6-min Pegboard and Ring test (6PBRT) in healthy Canadian adults
2017
-
Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study
2017
-
The cost burden of COPD in France: A retrospective analysis of an administrative primary care database
2017
-
The effect of an acute exacerbation of COPD (AECOPD) on balance after pulmonary rehabilitation (PR): a prospective study
2017
-
The views of health care providers’ (HCPs) and patients with Chronic Obstructive Pulmonary Disease (COPD) on pain in pulmonary rehabilitation (PR): A qualitative study
2017
-
Treatment patterns of COPD patients in France: A retrospective analysis of an administrative primary care healthcare database
2017
-
Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab
2017
-
Cardiovascular Safety Of Nintedanib In Subgroups By Cardiovascular Risk At Baseline In The Tomorrow And Inpulsis Trials
2017
-
An exploration of pain experiences and their meaning in people with chronic obstructive pulmonary disease (COPD)
2016
-
Cardiorespiratory physiotherapy as a career choice in Portugal
2016
-
Comparative efficacy of umeclidinium/vilanterol versus LABA/LAMA therapies in COPD: A network meta-analysis
2016
-
Inhaled diesel exhaust alters allergen-induced bronchial secretome in humans
2016
-
Investigating the interaction between bronchoconstriction and cough in asthma
2016
-
Postural abnormalities in people with chronic obstructive pulmonary disease (COPD)
2016
-
Specific parental atopy, sex of child and timing of introduction of 'allergenic' foods
2016
-
The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
2016
-
Tracking pulmonary exacerbations in preschool children using the lung clearance index
2016
-
Walk2Bactive: Patients' perspectives of a physical activity-focused intervention beyond pulmonary rehabilitation in COPD
2016
-
A novel approach to evaluate trunk geometric-motion during rest and with postural changes
2015
-
Accuracy of piezoelectric pedometer step counts in different wearing locations
2015
-
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults
2015
-
Does the lung clearance index track with disease progression in early childhood?
2015
-
Early life gut microbial alterations in children diagnosed with asthma by three years of age
2015
-
Feasibility of performing pulmonary function testing in cohort studies
2015
-
Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations
2015
-
QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study
2015
-
Relationship of cold frequency and virus detection to exacerbations in COPD patients
2015
-
Respiratory related hospitalizations in premature infants prophylaxed with palivizumab In the Canadian registry of palivizumab (CARESS)
2015
-
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study
2015
-
Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)–The LOTUSS study
2015
-
Self-report vs. pedometer steps in COPD: Are they similar?
2015
-
The dynamic change of IL-25 and its receptor expression during allergen challenge in asthmatic subjects
2015
-
Tri-level ventilation versus CPAP treatment in treatment of complex sleep apnoea syndrome
2015
-
Working with families: Lessons from a Canadian registry of palivizumab use
2015
-
Arm activity in daily life in chronic obstructive pulmonary disease (COPD)
2014
-
As-needed formoterol (F) in asthma: An analysis of the East-Asian subgroup of the RELIEF study
2014
-
As-needed formoterol (F) in asthma: An analysis of the East-Asian subgroup of the RELIEF study
2014
-
As-needed formoterol (F) in asthma: An analysis of the East-Asian subgroup of the RELIEF study
2014
-
Blockade of TSLP pathway alters asthma biomarkers
2014
-
Blockade of TSLP pathway alters asthma biomarkers
2014
-
Cluster analysis of objectively measured physical activity in 1001 COPD patients
2014
-
Does family support affect physical activity of patients with COPD? An exploratory study
2014
-
Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis
2014
-
Exposure to household air pollution and respiratory symptoms in Nepal: A cross-sectional study
2014
-
Mast cells infiltrate the alveolar parenchyma in young children with respiratory viral infections
2014
-
Respiratory syncytial virus (RSV) hospitalization in infants with congenital airway anomalies (CAA) in the canadian registry of palivizumab (CARESS) after prophylaxis (2005-2012)
2014
-
Ease of use of a two-strip dry powder inhaler (DPI) to deliver fluticasone furoate/vilanterol (FF/VI) and FF alone in asthma
2013
-
Efficacy and safety of once-daily (OD) fluticasone furoate (FF) 50mcg over 24 weeks in adults and adolescents with persistent asthma
2013
-
Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in adults and adolescents with moderate-to-severe persistent asthma
2013
-
Efficacy of budesonide/formoterol maintenance and reliever therapy in mild asthma
2013
-
Excess inhaled corticosteroid adherence may be a marker of uncontrolled asthma
2013
-
Family integration in pulmonary rehabilitation programmes: A pilot study
2013
-
Geographical variation of prevalence, and under-diagnosis of COPD in urban and rural communities of China: Finding from China Kadoorie Biobank of 0.5M people
2013
-
Impact of adherence to fluticasone propionate/salmeterol combination (FSC) therapy on the outcomes of patients with asthma: A population based study
2013
-
Interdependence of HIF1 alpha/TGF beta 1 activity in induction of pulmonary fibrosis
2013
-
Job exposure matrix development for SOC 2000 occupational codes
2013
-
Magnitude of the late allergen response in seasonal vs perennial allergen bronchoprovocation
2013
-
Mechanisms regulating enhanced alpha v beta 6 expression in pulmonary fibrosis
2013
-
Mechanisms regulating enhanced alpha v beta 6 expression in pulmonary fibrosis
2013
-
Neuromechanical uncoupling of the respiratory system during exercise in patients with mild COPD
2013
-
Objective moderate-to-vigorous physical activity in 1064 patients with COPD after stratification for gender, FEV1 and BMI
2013
-
Peripheral blood Th17 / Treg ratio increases in late asthmatic response
2013
-
Prevalence and determinants of COPD in 320,000 never smokers in China: Results from the China Kadoorie Biobank study
2013
-
RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012)
2013
-
RSV hospitalization in infants with neuromuscular disease in the Canadian registry of palivizumab after prophylaxis (2005-2012)
2013
-
Real-life asthma impairment: SABA use depends on smoking phenotype
2013
-
Systematic review of job exposure matrix used in population COPD studies
2013
-
The NLRP3 inflammasome is not activated in airway smooth muscle upon TLR2 ligation
2013
-
The burden of asthma in Canadian children and adolescents of South Asian descent
2013
-
Abnormalities in lung clearance index in CF infants diagnosed by newborn screening
2012
-
Alternative multiple breath washout outcomes for clinical trials in cystic fibrosis
2012
-
Assessing the standard and accuracy of chest x-ray reporting by medical physicians in an acute medical take
2012
-
Factors associated with compliance with palivizumab treatment in the Canadian rSV evaluation study for synagis (CARESS) registry (32005-2011)
2012
-
RSV hospitalization in Down syndrome in the Canadian Registry of Synagis (CARESS) following prophylaxis (2006-2011)
2012
-
Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011)
2012
-
Validation of multiple breath washout technology in healthy children and children with CF
2012
-
Drug-induced infiltrative lung disease.
2001
has subject area
Identity
International Standard Serial Number (ISSN)
-
0106-4347
-
0395-3890
-
0903-1936
-
0904-1850
-
1073-449X
Electronic International Standard Serial Number (EISSN)
-
0000-0000
-
1399-3003
-
1535-4970